The Ethos Podcast - What is the point of having company signatories?
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Ethos Podcast: Do Companies Still Need Signatories in Pharma Compliance?
This episode of the Ethos Pharmaceutical Ethics & Compliance Podcast explores a key question in the pharmaceutical industry: What is the point of having company signatories in today’s compliance landscape?
With compliance reviews increasingly outsourced to specialist agencies and AI-powered tools becoming more common, we ask whether in-house expertise is still essential.
Hosted by Dr Nick Broughton with guests Dr Ravi Pawa and Dr Sheuli Porkess, this discussion covers:
-
The business case for maintaining in-house expertise
-
Why accountability matters in compliance decisions
-
The limitations of AI in compliance and ethics
-
How effective oversight depends on subject-matter knowledge
This is a must-listen for anyone working in:
-
Pharmaceutical compliance
-
Ethics and regulation
-
ABPI code of practice
-
AI and compliance technologies
🔗 Watch the full discussion and subscribe for future episodes on pharmaceutical ethics, compliance best practices, and the evolving role of signatories in the life sciences industry.